Low baseline LDH level, high relative/absolute eosinophil counts, and relative lymphocyte counts are correlated with prolonged OS in melanoma anti-PD-1 and CTLA-4 treatment [146,147]. This evidence concerns the gene CTLA4 and melanoma.